Significance of serum 8-Hydroxydeoxyguanosine levels to the intima-media thickness of the carotid artery in type 2 diabetes

1. Maxwell CS, Wood RJ. Update on vitamin D and type 2 diabetes. Nutr Rev. 2011; 69:291-5.10.1111/j.1753-4887.2011.00393.xOpen DOISearch in Google Scholar

2. Unger J, Parkin CG. Type 2 diabetes: an expanded view of pathophysiology and therapy. Postgrad Med. 2010; 122:145-57.10.3810/pgm.2010.05.2152Open DOISearch in Google Scholar

3. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998; 339:229-34.10.1056/NEJM199807233390404Search in Google Scholar

4. Reaven GM. Relationships among insulin resistance, type 2 diabetes, essential hypertension, and cardiovascular disease: similarties and differences. J Clin Hypertens (Greenwich). 2011; 13:238-43.10.1111/j.1751-7176.2011.00439.xOpen DOISearch in Google Scholar

5. Bloomgarden ZT. World congress on insulin resistance, diabetes and cardiovascular disease: part 2. Diabetes Care. 2011; 34:e126-31.10.2337/dc11-0936Search in Google Scholar

6. Leinonen J, Lehtimaki T, Toyokuni S, Okada K, Tanaka T, Hiai H, et al. New biomarker evidence of oxidative DNA damage in patients with non-insulindependent diabetes mellitus. FEBS Lett. 1997; 417: 150-2.10.1016/S0014-5793(97)01273-8Search in Google Scholar

7. Loft S, Fischer-Nielsen A, Jeding IB, Vistisen K, Poulsen HE. 8-Hydroxydeoxyguanosine as a urinary biomarker of oxidative DNA damage. J Toxicol Environ Health. 1993; 40:391-404.10.1080/15287399309531806Open DOISearch in Google Scholar

8. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, et al. Oxidative damage to DNA in diabetes mellitus. Lancet. 1996; 347:444-5.10.1016/S0140-6736(96)90013-6Search in Google Scholar

9. Krapfenbauer K, Birnbacher R, Vierhapper H, Herkner K, Kampel D, Lubec G. Glycoxidation, and protein and DNA oxidation in patients with diabetes mellitus. Clin Sci (Lond). 1998; 95:331-7.10.1042/cs0950331Open DOISearch in Google Scholar

10. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998; 15:539-53.10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-SOpen DOISearch in Google Scholar

11. Kitamura A, Iso H, Imano H, Ohira T, Okada T, Sato S, et al. Carotid intima-media thickness and plaque characteristics as a risk factor for stroke in Japanese elderly men. Stroke 2004; 35:2788-94.10.1161/01.STR.0000147723.52033.9eOpen DOISearch in Google Scholar

12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28:412-9.10.1007/BF00280883Open DOISearch in Google Scholar

13. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 2002; 23:599-622.10.1210/er.2001-0039Open DOISearch in Google Scholar

14. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stressactivated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes. 2003; 52:1-8.10.2337/diabetes.52.1.1Open DOISearch in Google Scholar

15. Nourooz Nourooz-Zadeh J, Rahimi A, Tajaddini- Sarmadi J, Tritschler H, Rosen P, Halliwell B, et al. Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia. 1997; 40:647-53.10.1007/s001250050729Open DOISearch in Google Scholar

16. Madsen-Bouterse SA, Kowluru RA. Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Rev Endocr Metab Disord. 2008; 9:315-27.10.1007/s11154-008-9090-4Open DOISearch in Google Scholar

17. Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes. 2008; 57:1446-54.10.2337/db08-0057Open DOISearch in Google Scholar

18. Figueroa-Romero C, Sadid M, Feldman EL. Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord. 2008; 9:301-14.10.1007/s11154-008-9104-2Open DOISearch in Google Scholar

19. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the otterdam Study. Circulation. 1997; 96:1432-7.10.1161/01.CIR.96.5.1432Open DOISearch in Google Scholar

20. Kawamori R, Yamasaki Y, Matsushima H, Nishizawa H, Nao K, Hougaku H, Maeda H, Handa N, Matsumoto M, Kamada T. Prevalence of carotid atherosclerosis in diabetic patients: ultrasound high-resolution B-mode imaging on carotid arteries. Diabetes Care. 1992; 15:1290-4.10.2337/diacare.15.10.1290Open DOISearch in Google Scholar

21. Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97:1837-47.10.1161/01.CIR.97.18.1837Open DOISearch in Google Scholar

22. Goldstein BJ, Mahadev K, Wu X, Zhu L, Motoshima H. Role of insulin-induced reactive oxygen species in the insulin signaling pathway. Antioxid Redox Signal. 2005; 7:1021-31.10.1089/ars.2005.7.1021Search in Google Scholar

23. Shi Y, Patel S, Davenpeck KL, Niculescu R, Rodriguez E, Magno MG, et al. Oxidative stress and lipid retention in vascular grafts: comparison between venous and arterial conduits. Circulation. 2001; 103:2408-13.10.1161/01.CIR.103.19.2408Open DOISearch in Google Scholar

24. Hanley AJ, Williams K, Stern MP, Haffner SM. Homeostasis model assesstent of IR in relation to the incidence of cardiovascular disease: the Sam Antonio Heart Study. Diabetes Care. 2002; 25:1177-84. 10.2337/diacare.25.7.1177Open DOISearch in Google Scholar